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Abstract

SIRT6 AND PREMATURE AGING OF HUTCHINSON-GILFORD PROGERIA SYNDROME FIBROBLASTS.

By Helal A. Endisha, MSc.

A thesis submitted in partial fulfillment of the requirements for the Master of Science in
Molecular Biology and Genetics at Virginia Commonwealth University.

Virginia Commonwealth University, 2013.

Major Director: Gail E. Christie, Ph.D.
Department of Microbiology and Immunology

The genetic disease Hutchinson-Gilford Progeria Syndrome (HGPS) arises from a de novo single
nucleotide mutation (1824CT) in the LMNA gene. As a result, the mutated lamin A protein
(progerin) remains farnesylated and permanently attached to the nuclear membrane. Progerin
accumulates and deforms the nuclear membrane leading to an array of cellular abnormalities
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driving the cells to enter a state of permanent cell-cycle arrest early on in replicative age i.e.
premature cellular senescence. Cellular senescence has been extensively studied as one of the
contributing factors to aging in HGPS patients and other age-related diseases. There has also
been evidence to show that aging is accompanied by epigenetic changes and that epigenetic
manipulation can incite progeroid syndromes in mice. It has been found in this study that HGPS
fibroblasts express distinctly lower levels of SIRT6, a member of the sirtuin family of NADdependent protein deacetylases/ADP-ribosyltransferases, than normal fibroblasts. Findings
from this study demonstrate that overexpression of SIRT6 prevents a decrease in replicative
capacity and the onset of premature senescence in HGPS fibroblasts. Thus, SIRT6 may have
promising therapeutic implications for improving HGPS age-related pathologies.

1.INTRODUCTION

1.1 Hutchinson-Gilford Progeria Syndrome: Clinical Manifestations and Challenges
Hutchinson-Gilford Progeria Syndrome (HGPS) is a rare, fatal genetic disease affecting 1 in 4-8
million people worldwide, in which the individual undergoes an advanced aging process.1
Despite being born with a de novo mutation2,3,5, affected individuals display no signs of disease
at birth with symptoms manifesting at age 1 or 2 years.1,3 Symptoms are first noticed as a
‘failure to thrive’ and progress into alopecia (loss of hair including scalp and eyebrows),
wrinkled skin, frailty, loss of subcutaneous fat, skeletal dysplasia and hypoplasia, dry and thin
skin, and osteoporosis.1 These symptoms leave young children with the appearance and health
conditions of an aged individual (Figure 1). HGPS is coined a “segmental aging syndrome” as
patients lack certain typical features of aging such as neurocognitive decline or increased
incidence of cancer.4 In 90% of individuals with HGPS, death typically occurs at a mean age of
13 due to progressive atherosclerosis of the coronary and cerebrovascular arteries.3
1.2 HGPS: Molecular Pathogenesis
Lamins are filamentous structures present in the nuclear membrane that are essential for
regulating chromatin, nuclear integrity and nuclear shape.4 About 90% of HGPS cases (referred
to as ‘typical HGPS’) are due to a de novo single nucleotide substitution in which a cytosine is
mutated to a thymine at position 1824 of the LMNA gene which encodes for lamin A and its
1

exon 10 splice variant, lamin C.2,5,30 The mutation results in a silent polymorphism (G608G),
which consequently activates a cryptic splice donor site resulting in a truncated prelamin A
transcript and ultimately, a mutated lamin A product with a 50 amino-acid deletion (progerin).5
The less characterized atypical progeroid syndrome (APS) makes up the remaining 10% of HGPS
cases. APS cases are the result of different heterozygous missense LMNA mutations such as
P4R, E111K, D136H, E159K, and C588R. Individuals with APS display a slightly delayed onset of
clinical manifestations and live for as long as a reported 51 years.6 There has also been reported
cases of the occurance of APS in siblings from parental consanguineous families, suggesting an
alternative pattern of autosomal recessive inheritance.7

Under normal conditions, prelamin A undergoes a series of posttranslational modifications
required for the production of mature lamin A protein and subsequent incorporation into the
nuclear lamina (Figure 2). The prelamin A protein contains a C-terminal CAAX motif (C: cysteine;
A: aliphatic amino acid; X: any amino acid) where a farensyl group (C15) is added to the cysteine
by the enzyme farensyltransferase, rendering the protein more hydrophobic and allowing it to
be embedded in the nuclear membrane.8,9 The three terminal amino acids are then cleaved by
the ZMPSTE24 endoprotease followed by carboxymethylation of the terminal farnesylated
cysteine. A second cleavage step by ZMPSTE24 removes the modified cysteine along with 14
amino acids upstream of it allowing the mature lamin A to be released from the nuclear
membrane and inserted into the nuclear lamina. The second ZMPSTE24 cleavage site of
prelamin A is within the 50 amino acids missing from individuals with typical HGPS.
Consequently, the mutated lamin A protein is permanently farnesylated and irreversibly
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anchored in the nuclear membrane.9 Since the alternate splice site is used about 40% of the
time during prelamin A processing, the loss of lamin A and accumulation of progerin1 disrupts
normal lamina function and results in nuclear abnormalities such as laminal thickening, blebs,
disrupted heterochromatin structure and clustering of nuclear pores.10 It is conjectured that
progerin-mediated aberrations cause cells to exit the cell cycle and undergo cellular senescence
(see section 1.3). Furthermore, it is believed that an accumulation of senescent cells disrupts
tissue homeostasis and contributes to organismal aging.11 In the case of HGPS, induction of
cellular senescence occurs at a much more rapid pace, presumably contributing to the
pathological aging phenotypes so characteristic of this progeroid syndrome.

3

Figure 1. Physical Characteristics of HGPS with Age. (A) A girl with HGPS at ages 3 months, 13
months, 3 years 11 months, 6 years 6 months, and 9 years. (B1) Representative image of
alopecia in a 3-year old child with progeria. (B2) Representative image showing skin findings in
a 7-year old child with progeria. The image shows areas of discoloration, speckled
pigmentation, and tight skin restricting movement. (B3) Knee joint restriction in a 3-year old
child with progeria. (C1) Carotid artery MRI in a 4-year old with progeria demonstrating patency
of the right common carotid artery and complete occlusion of the left common carotid artery.
(C2) Radiographic image indicating acroosteolysis (i.e. resorption of the distal bony phalanges)
with an ill-defined phalangeal edge. (C3) Clavicular resorption. (C4) Coxa valga i.e. deformity of
the hip where the angle formed between the head and neck of the femur and its shaft is
increased. (Photos and MRIs are courtesy of the Progeria Research Foundation)
Reproduced with permission from Pediatrics, Vol. (120), Pages 834-841. Copyright 2007 by the AAP.
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B

Figure 2. Effects of the LMNA Mutation on Posttranslational Modifications in HGPS. (A)
Normal splicing results in lamin A. The 1824 CT mutation in typical HGPS activates a cryptic
splice donor site in exon 11 that deletes 150 bases from the mRNA. The resulting truncated
abnormal lamin A protein is called progerin. (B) Posttranslational lamin A processing. A farnesyl
group binds to the cysteine residue (C) at the C-terminal by the enzyme farnesyltransferase.
The lamin A binds to the membrane of the endoplasmic reticulum by means of the farnesyl
group. ZMPSTE24 then cleaves the terminal three amino acids, after which the farnesylated
cysteine is carboxymethylated (0CH3). ZMPSTE24 then cleaves the modified cysteine along with
14 amino acids upstream of it releasing the mature lamin A. Due to the abnormal splice, the
ZMPSTE24 recognition site is deleted in HGPS and progerin remains farnesylated and bound to
the membrane.
Figure adapted from “Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina.”
Korf B. (2008), 358(6), 552-555.
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1.3 Telomeres and Senescence
A recent review (“The Hallmarks of Aging”) characterized aging as ‘the time-dependent
functional decline that affects most living organisms’.11 They propose as many as 9 possible
hallmarks that contribute to organismal aging. Genetic instability (discussed later) and telomere
attrition due to defects in nuclear architecture are two of the suggested hallmarks. Normal cells
have a finite replicative potential depending in part on their species and tissue origins, age of
donor and genetic background, eventually undergoing senescence.12 Telomeres are DNA
sequences at the end of chromosomes that are characterized by tandem repeats of TTAGGG in
vertebrates. The length of repeats at chromosome ends varies between individual
chromosomes and also varies depending on tissue type, donor age (chronological age) and the
replicative history (physiological age) of the cells.13 However, a minimum number of repeats are
required at chromosome ends to recruit sufficient telomere-specific proteins for the formation
of functional telomeres that differentiates normal ends from double-stranded breaks.
Telomeres can be extended by a ribonucleoprotein complex called telomerase, which is
composed of a protein component (Telomerase Reverse Transcriptase (TERT)) and an RNA
primer sequence (Telomerase RNA Component (TERC)).14 Some cancers achieve telomere
elongation via the Alternative Lengthening of Telomeres (ALT) pathway, which relies on
recombination-mediated elongation.15 Telomeres play a role in ensuring chromosomal stability
by preventing end-to-end fusions of chromosomes and proper segregation of genetic material
into daughter cells during cell division.13 In most mammalian somatic cells, telomeres shorten
with each cell division as a result of incomplete DNA replication since telomeric DNA is
replicated from internal origins and not from the very end of the chromosomes. DNA
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polymerase can only synthesize DNA in a 5’ to 3’ direction by adding polynucleotides to RNA
primers upstream along the length of the DNA. This is followed by replacement of the RNA
strand with DNA. At the chromosome ends, DNA polymerase cannot replace the RNA primer
because a template no longer exists in the 5’ direction to place another primer.16 This ‘end
replication problem’ along with the lack of expression of telomerase by most normal somatic
cells leads to telomere shortening with each cell cycle. Consequently, telomeres of fibroblasts
from individuals of old age are much shorter than those of younger individuals.12.13 There are
numerous assays to estimate telomere length, such as by means of the length distribution of
terminal restriction fragments (TRF), which contains the telomeric TTAGGG tract as well as
telomere-like and non-telomeric sequences.13,17 Germ cells, which express telomerase, have
mean telomere lengths of 10-15 kb while presenescent cultures from fetal or neonatal tissues
typically have mean telomere lengths of 8-10 kb.18 Somatic cells lose 50-200 bp per doubling.19
Telomere loss can also occur due to sporadic events such as failed telomeric DNA repair or
problems during replication. The progressive attrition of telomeric DNA leads to a loss of the
telomere capping proteins, exposing DNA breaks that activate cell cycle arrest and senescence
(telomere-dependent senescence).20 The resulting limitation in the replicative potential of cells
that have undergone telomere shortening with age limits their proliferation and leads to the
loss of cells and tissue function. Unlike germ cells, stem cells and cancer cells, somatic cells lack
telomerase activity and gradual telomere loss and senescence are inevitable.21 Ectopic
expression of hTERT has been demonstrated in many studies22,23 to extend cellular lifespan
(normal human diploid fibroblasts and HGPS fibroblasts) to at least twice the life span at which
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the uninfected cultures senesced (30-60 population doublings for normal fibroblasts), thus
extending in vitro lifespan.24

Previous research12 has shown that when compared with age-matched controls, the average
telomere length in fibroblasts from HGPS patients was significantly shorter.25 The abnormally
short telomere length in HGPS fibroblasts was not seen in HGPS hematopoietic cells which
either did not express detectable LMNA or expressed it at much lower levels.12 This suggests
that the expression of progerin (either direct or indirect) is involved in the generation of short
telomeres. Since telomeres have been shown to attach to the nuclear matrix, dysfunction of the
nuclear architecture in HGPS may impair telomere structure and function. The lamina serves as
a scaffold for multi-protein and chromatin containing complexes, which have a role in the
maintenance, repair and replication of telomeric DNA, the disruption of which could lead to an
increase in replication errors, failure to repair DNA damage and impairment in the accessibility
of enzymes.14 Thus, the lamina has been suggested to have a critical role in the maintenance of
telomere length.12

During cellular senescence, normal fibroblasts change their morphology from a spindle shape to
an enlarged, flattened and irregular shape. Using senescence-associated β-Galactosidase (SA βgal) as a histochemical biomarker, senescent cells can be identified by the expression of a
lysosomal β-galactosidase enzyme, which cleaves the substrate X-Gal at pH 6 forming a blue
precipitate.26 During exponential growth, replicative age in culture can measured in terms of
population doublings (PDs).
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Thus, pathological telomere dysfunction in HGPS has been reported to be caused by aspects
such as dysfunctional nuclear architecture due to progerin accumulation, rapid telomere
shortening, and an inherently shorter than average telomere length. 12 It is believed that the
resulting premature cellular senescence is one of the major elements contributing to the
accelerated aging phenotypes developing in children with HGPS.11

Apart from telomere dysfunction, cellular senescence can be triggered by a multitude of factors
including, but not limited to, stress, oncogene activation, chromatin perturbation (discussed
later), and DNA damage.52

1.4 DNA Damage and Cellular Senescence
It has been revealed that low levels of progerin protein are present in skin derived from elderly
individuals. In normal fibroblast cultures, progerin expression appeared to accumulate with
increasing replicative age, albeit still relatively low when compared to the amount of progerin
accumulating in HGPS fibroblastic cultures.3,10,30 Research by McClintock et al.30 suggests that
progerin expression may be a biomarker of normal cellular aging and a precursor for
senescence in older individuals. In addition to their structural functions, lamins form
nucleoplasmic foci containing the replicative proteins PCNA (proliferating-cell nuclear antigen)
and DNA polymerase δ, both of which are necessary for the systematic initiation of S-phase
replication in particular, fork progression at replication centers. The accumulation of progerin
on the nuclear membrane results in a loss of these nucleoplasmic lamin A foci, causing
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replication fork stalling and DNA double-strand breaks (DSBs) as well as a loss of
heterochromatin and dysmorphic interphase nuclei.31

Another consequence of progerin accumulation and lamina disruption is the failure to repair
DNA damage, as previously mentioned (see section 1.3). DNA damage accumulation, the
reduction of replicative proteins and the prevention of access of DNA repair proteins to sites of
DNA DSB (discussed later), are collectively responsible for the phenotypes associated with
HGPS and may have causal roles in normal aging.21 The accumulation of DNA damage activates
DNA damage and replication checkpoints, which reduce cell cycle progression and halts
replication, thus preventing DNA lesions from being converted to inheritable mutations. 32 The
two main kinases responsible for initiating these checkpoints are Ataxia-Telangiectasia Mutated
(ATM) and ATM- and Rad3-Related Protein (ATR). There are two main checkpoints during the
cell cycle controlling cell division, the G1/S and the G2/M, whose functions are to assess DNA
damage detected by sensor mechanisms. ATM plays a role in cell-cycle delay in response to
DNA DSBs, while ATR is activated by a broad range of DNA damage and replication
interference.32,33 D’Adda di Fagagna et al.32 reported that in telomere-initiated senescence, a
checkpoint response similar to that in cells with DNA damage stress was activated involving
ATM, ATR and their downstream kinases Checkpoint Kinase 1 (CHK1) and Checkpoint Kinase 2
(CHK2). The activation of ATM and ATR is identified by their clustering into distinct nuclear foci
and it is their activation that is responsible for decreased cell cycling and reduced replicative
capacity in aged progeroid cells.32 This led researchers to assume that DNA damage response
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and telomere-initiated senescence activate the same signaling pathway. However, to determine
whether the activation of ATM and ATR is directly related to the accumulation of progerin, Liu
et al.33,34 transfected HeLa (cervical cancer) cells with progerin. By immunofluorescence
analysis, they observed translocation of the checkpoint kinases to the nucleus, in contrast to
cells transfected with an empty vector which showed most of ATR located in the cytoplasm.
This finding indicated that the accumulation of progerin led to the activation of ATM and ATR
due to accumulated DNA damage, which contributes to both aging and cellular senescence.21
A family of proteins required for the phosphorylation and activation of the ATM and ATR
checkpoint kinases are the BRCA1 C Terminus (BRCT) domain. 53BP1 (p53-binding protein 1), a
member of the BRCT protein family, is one of the mediators between early detection of a DNA
lesion and the transducer kinases such as CHK1 and CHK2, which target downstream DNAdamage response components, including p53.35,36 Phosphorylation of the transcriptional
regulator, p53, by ATM and kinases downstream of ATM results in cell cycle arrest (senescence)
or apoptosis to prevent DNA replication and cell division in the presence of DNA damage.21
53BP1 undergoes nuclear relocalization to focal structures in response to DNA damage to aid in
DNA repair. Knockout of 53Bp1 (53Bp1-/-) leads to genome instability characterized by increased
levels of chromatid gaps, breaks and exchanges in addition to aneuploidy and tetraploidy in the
absence of exogenous DNA damage. Furthermore, 53Bp1-/- cell lines exhibit elevated sensitivity
to exogenous DNA damage relative to wild-type cells, verifying the involvement of 53BP1 in
DNA repair.36 Using 53BP1 foci as an indicator of DNA DSBs, Liu et al.38 observed significantly
more 53BP1-positive DNA damage foci per nuclei in primary dermal fibroblasts from 2 different
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HGPS strains than those observed in normal fibroblast controls, indicating greater DNA DSBs in
these progeria cells.
Low passage HGPS cells grow relatively well when compared to normal human primary
fibroblasts; however their growth capacity is limited and they quickly begin to senesce.14 An
increase in dysmorphic nuclei and number of γH2AX (phosphorylated histone H2AX) foci are
seen. H2AX is a minor histone H2A variant, which is phosphorylated at Ser139 to γH2AX and is
important for sensing early detection of a DSB. γH2AX is required for the focal recruitment of
53BP1 and other DNA repair factors.32 Similar to 53BP1 foci; it is used as a surrogate for nuclear
sites of DSBs. As HGPS cells are passaged in culture, they accumulate endogenous DNA damage
and exhibit higher levels of γH2AX. Increased levels of phosphorylated CHK1 and CHK2 are also
seen as a result of persistent ATM and ATR activation, which ultimately results in cell growth
arrest in HGPS cells.31
Zou et al.31, have reported that the accumulation of DSBs in HGPS is likely due to a deficiency in
DNA repair. They found that in HGPS cells, xeroderma pigmentosum group A (XPA), which is
normally an essential factor for nucleotide excision repair (NER), binds to the stalled replication
forks, denying the access of repair proteins such as Rad50, Rad51 and 53BP1 to the DSBs for
repair. As a result, the accumulation of DSBs is implicated in the genome instability presented.
Collectively, findings in the literature indicate that DNA damage is accumulated in HGPS cells as
a result of defective DSB repair. The DNA repair failure is not a result of defects in the DNA
repair machinery; rather, it is more likely due to the dysfunctional nuclear architecture in HGPS
cells. The persistent activation of the ATM/ATR pathway and subsequent cell cycle arrest drive
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the cells to enter a senescent state. Moreover, the restricted access of repair proteins to sites
of DSBs due to bound XPA leads to an accumulation of unrepaired DSBs. Whereas DNA repair or
damage response genes are not defective in this laminopathy, a connection exists between the
mutated lamin A proteins and the disruption of DNA metabolism resulting in genome instability
and premature aging phenotypes.29
1.5 Current Therapeutic Treatments
A class of drugs called farnesyl transferase inhibitors (FTIs) used to treat progeria cells in vitro
demonstrated amelioration of the morphologic nuclear abnormalities such as laminal
thickening and blebbling.4 In a clinical trial published in 2012,27 weight gain, improved bone
structure and increased flexibility of blood vessels were observed in children. FTIs act by
reversibly binding to the farensyltransferase CAAX binding site, thus inhibiting progerin
farensylation and its incorporation into the nuclear membrane.27 FTIs exhibit partial correction
of the abnormal cellular and disease phenotypes, and delay mortality in progerin-expressing
mice; however, the levels of γH2AX and phosphorylated CHK1 and CHK2 in HGPS cells were not
reduced, neither was the frequency of DSBs suggesting that the restoration of nuclear shape is
not sufficient to overcome the genomic instability present in HGPS cells.3,28,33

Thus, progerin farnesylation is found to contribute to the toxicity arising from the accumulation
of progerin, however, there must be other factors accounting for the genomic instability seen in
HGPS fibroblasts. Whereas DNA repair or damage response genes are not defective in this
laminopathy, a connection exists between the mutated lamin A proteins and the disruption of
DNA metabolism resulting in genome instability and premature aging phenotypes.29
13

1.6 The Role of Sirtuins in DNA Repair and Aging
As previously mentioned, both genomic instability and telomere attrition contribute to cellular
senescence, which itself contributes to aging. Additionally, alterations in DNA methylation
patterns, histone modifications, and chromatin remodeling all constitute age-associated
epigenetic changes.11 Members of the sirtuin family of NAD+-dependent protein deacetylases
and ADP ribosyltransferases have been widely studied as potential anti-aging factors.39-44 The
Silent Information Regulator-2 gene (Sir2) encodes an NAD-dependent histone deacetylase that
links chromatin regulation, genomic stability, and life span in Saccharomyces cerevisiae, a
species of yeast. By means of chromatin silencing, Sir2 inhibits transcription and suppresses
recombination at ribosomal DNA (rDNA) repeats.39,40,42 In S. cerevisiae with mutations in Sir2,
increased genomic instability indicated by recombination at ribosomal DNA (rDNA) repeats is
seen. This ultimately leads to a shortened replicative life span. Homologous recombination
between rDNA repeats leads to the formation of rDNA circles, which causes senescence in yeast
and is thought to be the process by which yeast age.46 An overexpression of sir2 was found to
prevent the accumulation of rDNA circles and thus increase replicative life span.46 The increase
in lifespan due to extra copies of sir2 was reported not only in yeast, but also in the
multicellular organisms, C. elegans and D. melanogaster.41
There are seven Sir2 family members in mammals; SIRT1-SIRT7.39 Of particular interest in the
context of regulation of life span, chromatin and genomic integrity is the mammalian SIRT6.
Mostoslavsky et al.42 found the SIRT6 protein to be primarily nuclear by immunostaining and
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co-fractioned with histones within the chromatin/nuclear matrix subfraction, indicating that the
SIRT6 protein favorably associates with chromatin within the nucleus. Furthermore, SIRT6-/mice were generated and showed no abnormalities at birth apart from a reduced body size
shortly after birth. At about 3 weeks, the mice exhibited degenerative phenotypes such as loss
of subcutaneous fat, lordokyphosis, colitis, severe lymphopenia and failed to thrive. The mice
ultimately died at postnatal day 24. Recalling the phenotypes expressed in children with HGPS,
SIRT6-/- mice exhibited some overlapping pathologies with those of premature aging. These
findings hint that there may be a role for SIRT6 in the regulation of life span and perhaps the
prevention of the development of progeroid pathologies.
SIRT6 has been found to deacetylate the histone H3 lysine 9 residue (H3K9) at the telomeres
consequently stabilizing the association of the Werner protein (WRN) with telomeres.44 WRN is
a DNA metabolic factor, which helps maintain the structure and integrity of DNA and is mutated
in another form of progeria, Werner Syndrome.40 The depletion of SIRT6 in human diploid
fibroblasts by SIRT6 knockdown significantly inhibited the association of WRN with telomeric
chromatin.44 The subsequent telomere dysfunction and genomic instability implied a
requirement of SIRT6 for the stabilization of WRN with telomeric chromatin. In addition, SIRT6
is recruited and deacetylates H3K9 at the promoters of genes activated by the NF-κB
transcription factor, silencing gene expression and limiting NF-κB signaling.39 Hyperactive NF-κB
signaling is a significant factor resulting in degenerative phenotypes and early death in SIRT6deficient mice, revealing a potential role for SIRT6 in the regulation of gene expression and its
effect on genomic stability and aging.40

15

McCord et al.40 have shown that SIRT6 plays a role in DNA DSB repair. They report that SIRT6
associates with chromatin in response to DNA damage and stabilizes the DNA DSB repair factor,
DNA-dependent kinase (DNA-PK), at the DSBs. The DNA-PK holoenzyme is a central regulator of
DNA DSB repair in mammalian cells.40 Through the use of a stringent chromatin fractionation
protocol, McCord et al.40 revealed that upon DNA damage, more SIRT6 associates with
chromatin, indicating a possible dynamic association of SIRT6 with chromatin modulated by
DNA damage. Furthermore, upon the generation of DNA DSBs, increased levels of chromatinassociated DNA-PKs were observed when compared to no change in DNA-PKs levels in SIRT6
knock down (KD) cells. To determine whether increasing SIRT6 levels can further drive DNA-PKs
to DSBs, SIRT6 was overexpressed using a retrovirus in HeLa cells. About a 3 fold increase in
DNA-PKs was observed at the DSB, in contrast to a reduction in the DNA-PKs signal in cells
expressing the catalytically inactive SIRT6 mutant protein.40 Collectively, these experimental
data are consistent with SIRT6 being required for the recruitment of DNA-PKs to chromosomal
DSBs, highlighting the significance of SIRT6 in chromatin regulation, DNA repair and the
prevention of aging-like degenerative phenotypes.
On the other end of the spectrum, in 2012, Kanfi et al.41 showed that SIRT6 overexpression led
to increased longevity in male mice further emphasizing the importance of SIRT6 in regulating
mammalian longevity.
1.7 SIRT6 and its potential role in DNA repair in HGPS
SIRT6 has been associated with DNA repair and telomere maintenance, as well as having
functions in attenuation of inflammation and glucose homeostasis.49 Michishita et al.49 reported
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that SIRT6 knockdown (S6KD) human fibroblasts have a marked shortened replicative lifespan,
undergoing premature senescence (as measured by senescence-associated β-galactosidase
histochemical staining) about ten population doublings before control cells. Mostoslavsky et
al.42 found that multiple independent Sirt6-/- mouse embryonic fibroblast (MEF) lines had a
smaller fraction of S phase cells than control wild type cultures, indicating that the absence of
Sirt6 reduces proliferative rates. These findings have lead researchers to conclude that SIRT6 is
essential in maintaining a normal replicative life-span and in preventing the premature
senescence in vitro. Furthermore, A. Cardus et al.44 showed that in SIRT6-depleted human
endothelial cells, there was a significant increase in γH2AX foci formed at sites of DNA damage
and dysfunctional telomeres. They observed a concurrent increase in the appearance of
telomere dysfunction-induced foci (TIFs), i.e. sites where γH2AX foci co-localized with telomere
repeat binding factor-1 (TRF-1) signals suggesting that SIRT6 mitigates DNA damage and
telomere dysfunction and that SIRT6 may be required for functional DNA repair.
Thus, the presence of SIRT6 has been demonstrated to protect different cell types from
telomere and genomic DNA damage and improve replicative capacity. By targeting multiple
cellular defects that contribute to cellular senescence, the manipulation of SIRT6 may be
applied to the prevention of the onset of premature cellular senescence and improving agerelated pathologies.
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1.8 HYPOTHESIS
The parallels between the degenerative phenotypes observed in SIRT6-deficient cells/mice and
HGPS fibroblasts/patients are striking. It is of interest to note that progeria research has led to
the discovery that progerin accumulates in cultures of normal fibroblasts with increasing
chronological and physiological age.30 Histone modifications are a category of epigenetic
alterations thought to contribute to cellular senescence. To date, endogenous SIRT6 expression
levels have not been assessed HGPS fibroblasts. Moreover, essentially nothing is known about
the effect of histone modifications via ectopic SIRT6 expression on the induction of senescence
in HGPS cells. Based on experimental data generated from the aforementioned experiments, it
was hypothesized that (1) HGPS fibroblasts will express lower levels of SIRT6 protein than
normal fibroblasts, which contribute to DNA damage and premature senescence, and (2)
Overexpressing SIRT6 will prevent premature senescence in HGPS fibroblasts. To test these
hypotheses the following specific aims were proposed:
Aim 1: Determine the endogenous levels of SIRT6, frequency of DNA damage foci, βgalactosidase positivity and population doubling time of dermal fibroblasts derived from
individuals with HGPS compared to fibroblasts from normal donors.
Aim 2: Determine whether SIRT6 overexpression in HGPS fibroblasts reduces the frequency of
DNA damage foci, β-galactosidase positive staining and improves proliferative capacity.
The data generated from the proposed studies will provide novel insight into the link between
epigenetic alterations and age-related pathologies in HGPS and normal fibroblasts. The ectopic
expression of SIRT6 in preventing the onset of premature senescence in HGPS may offer an
18

innovative method to reduce the accumulated DNA damage expressed in HGPS, which was not
reduced by FTIs.33
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2. Materials and Methods

2.1 Cell Culture Methods
Table1. List of Cell Lines
Cell Line

Description

Cell Type

Sex

Age

(Catalog ID)
AG01972

HGPS

Fibroblast

Female

14YR

AG11513

HGPS

Fibroblast

Female

8YR

GM00969

Apparently healthy
non-fetal tissue

Fibroblast

Female

2YR

AG09602

Gerontology
Research
Center
Cell
Culture
Collection

Fibroblast

Female

92YR

Source: Coriell Institute for Medical Research (Camden, NJ).
Mycoplasma (bacterial) contamination induces cellular changes such as changes in metabolism
and cell growth.47 It also poses biosafety concerns in the lab and allows for the possibility of
cross-contamination. For these reasons, mycoplasma testing using the LookOut ® Mycoplasma
PCR Detection Kit (Sigma, MP0035) was performed on all cell cultures to ensure the validity of
subsequent study results. Mycoplasma negative cells were grown at 37°C in 5%CO2 in Minimum
Essential Medium Eagle (EMEM, 1X) with Earle’s salts (Cellgro) supplemented with 15% (v/v)
fetal bovine serum (FBS) (Invitrogen), 100x MEM non-essential amino acids (NEAA) (Cellgro),
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200mM L-Glutamine (Gibco) and antibiotic/antimycotic (ABAM) (Invitrogen). Cells were
passaged by standard Trypsin-EDTA dispersion aseptically under a laminar flow hood. For longterm storage, cells were cryopreserved in cosmic calf serum (CCS) (Invitrogen) + 10% dimethyl
sulfoxide (DMSO) (Fisher Scientific, BP231-100) and placed in an isopropanol freezing chamber
at -80°C. Cells were then transferred to a liquid nitrogen tank.
Population doublings were calculated from cell counts taken at each passage, where PD =
[log(N /Xo)] / log 2 (N=final cell count, Xo=initial cell count).
2.2 Lentiviral Infections and Constructs
SIRT6 and empty vector lentiviral supernatants were obtained from the Biological
Macromolecule Shared Resource Core at Virginia Commonwealth University. The SIRT6 gene
was cloned in a pcDNA3.1+ vector backbone (Addgene, Plasmid 13817) (Figure 3). SIRT6 was
expressed in the pCDH-CMV-MCS-EF1-Puro expression lentivector (System Biosciences) (Figure
4), which allows for stable, efficient, long-term expression of the SIRT6 gene in the normal and
HGPS fibroblasts. GM00969, AG11513 and AG01972 cells were each seeded in triplicate in
60mm dishes at a density of 2x105 cells per dish. For each cell strain, a plate of uninfected cells
was included as a control. Cells were infected at a multiplicity of infection of 1.0. To determine
the volume of lentivirus particles to add to each well, the following equations were used:
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A transduction unit per ml (TU/ml) is the measurement of how much virus infects a target cell.
The estimated transduction units for the SIRT6 and empty vector lentiviral supernatants were
2x107 and 1x107 TU, respectively.
Media containing 10µl of SIRT6 lentiviral supernatant or 20µl of empty vector control was
added to dishes that were 60-70% confluent. To increase the transduction efficiency, polybrene
(Santa Cruz Biotechnology, sc-134220) was added to the media at a final concentration of
8µg/ml in all dishes including the uninfected cells. Cells were infected overnight in the
incubator and replaced with fresh media the next day. After allowing the cells to recover for a
day, puromycin (Sigma, P9620) was added to the culture medium to selectively kill all
uninfected cells. Prior to the drug selection of infected cells, a puromycin ‘Kill Curve’ was
performed on uninfected GM00969, AG11513 and AG01972 cells to determine the optimal
concentrations of drug. Specifically, the cells were seeded at ~50% confluency into the wells of
a 48-well plate with 250µl fresh medium. The next day puromycin (range 0-900ng/ml) was
added to the wells. The cells were microscopically monitored every day for 5 days and the
minimum concentration of puromycin that caused complete cell death in 3-5 days was selected.
A puromycin concentration of 0.7µg/ml killed both normal fibroblasts and HGPS cells in 4 days.
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FIGURE 3. SIRT6 Gene Cloned in a pcDNA3.1+ Vector Backbone. SIRT6 was digested using
EcoRI restriction enzymes from the pcDNA3.1 vector at EcoRI recognition sites.
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Figure 4. pCDH-CMV-MCS-EF1-Puro Lentiviral Expression Vector with a CMV Target Gene
Promoter. The lentiviral vector was digested at the MCS using the same restriction enzyme
(EcoRI) used to digest the pcDNA3.1 plasmid.
Key features: MCS – multiple cloning site for cloning the gene of interest; CMV – target gene
promoter; SV40 polyadenylation – enables efficient termination of transcription of recombinant
transcripts; SV40 origin – for stable propagation of the pCDH in mammalian cells; pUC origin –
for high copy replication and maintenance of the plasmid in E.coli cells; Ampicillin resistance
gene – for selection in E.coli cells; Puromycin resistance gene – Puromycin-resistant marker for
selection of the transfected cells.

Human dermal fibroblasts (HDF) under Tet-on control to induce EGFP-Progerin and EGFP-Lamin
A were kindly provided by Dr. Tom Misteli from the National Cancer Institute (Bethesda, MD).
The fibroblasts are hTERT immortalized; therefore, population doublings were not monitored.
For my experiments, fibroblasts were seeded in our standard fibroblastic growth media (EMEM
+ 15%FBS + 100X NEAA + 100X L-glut + 100X ABAM) supplemented with doxycycline to induce
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expression of progerin. Progerin production was induced with 750ng/ml doxycycline for 4, 8
and 14 days in culture. Through correspondence with Dr. Nard Kubben from the Misteli Lab, a
level of progerin equal to half the intensity of endogenous lamin A, on a western blot, was
recommended to induce proper aging effects.
2.3 Antibodies
Table 2. List of the primary and secondary antibodies used.
A

PRIMARY ANTIBODIES
Rabbit anti-SIRT6 (Cell Signaling, 2590)
Mouse monoclonal anti-acetyl-Histone H3 (Ac-Lys9) (Sigma, H0913)
Mouse anti-human 53BP1 (BD Transduction Laboratories, 612523)
Mouse anti-progerin antibody (Abcam, ab66587)
Mouse monoclonal anti β-actin (Santa Cruz, sc-47778)

B

SECONDARY ANTIBODIES
Alexa Fluor 488 goat anti-rabbit IgG (H+L) (Invitrogen)
Alexa Fluor 568 goat anti-mouse IgG (H+L) (Invitrogen)
Goat anti-mouse IgG (H+L)-HRP conjugate (Biorad, 172-1011)
Goat anti-rabbit IgG (H+L)-HRP conjugate (Biorad, 172-1019)
List of the primary (A) and secondary (B) antibodies used throughout the study.
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2.4 Western Blotting
Cells were lysed in RIPA buffer (25mM Tris-HCl (pH 7.6), 150mM NaCl, 1%NP-40, 1% sodium
deoxycholate, 0.1%SDS) containing 1x Halt Protease and Phosphatase Inhibitor Cocktail
(Thermo Scientific). Lysates were maintained on ice for 20-30 minutes and then pipetted using
a 21-½ G needle with 3ml syringe ten times to form homogenous lysates. Tubes were then
centrifuged at 13,000g for 20 minutes at 4°C to clarify the supernatant of lysed proteins from
undigested cellular constituents. Pellets were discarded and supernatants were kept on ice
while protein concentrations were quantified using the BioRad Protein Assay (BioRad
Laboratories) and read at 750nm on the 2800 UV/Vis Spectrophotometer by Unico. A standard
curve was established by using a serial dilution series of known concentration of bovine
albumin serum (BSA) then plotting the ‘average blank-absorbance’ for each BSA standard vs. its
concentration in µg/ml.52 The protein concentration of each sample was then calculated by
using the equation x=128.2y/volume (x: protein concentration in volume of sample measured,
y: absorbance at 750nm, volume: volume of sample measured). Lysate volumes corresponding
to 25-30µg protein were resolved on either an 8% or 10% sodium dodecyl sulfate
polyacrylamide gel (SDS-PAGE) gel depending on protein size being evaluated. 10µl of Precision
Plus Protein™ Dual Color Standards (Biorad #161-0374) were loaded in the first well of each gel
to be used as a molecular weight standard. A higher percentage gel leads to smaller pore size
and is used to resolve smaller proteins. After electrotransferring the proteins from the gel to a
nitrocellulose membrane, the membrane was blocked for 1 hour at room temperature or
overnight at 4°C using 5% blocking buffer (5g dry milk in 100ml PBS/Tween). The nitrocellulose
membrane was then incubated with appropriate concentrations of primary antibody in 5%
26

blocking buffer overnight at 4°C with continuous shaking. After washing 3 times with
PBS/Tween for 5 minutes each wash, the membrane was incubated with the appropriate
dilution of secondary antibody in 5% blocking buffer for an hour at room temperature followed
by 3 washes, 15 minutes each. SuperSignal® West Pico Chemiluminescent Substrate (Thermo
Scientific, 34077) is an enhanced chemiluminescent (ECL) substrate for detection of horse
radish peroxidase activity from secondary antibodies and was added to the membrane for 1
minute.53 Films were then developed using the Kodak X-OMAT 2000A Processor.
2.4.1 To Detect Endogenous SIRT6 Levels in HGPS Compared to Normal Fibroblasts. The
samples tested included three different HGPS strains (AG11513, AG01972 and AG03199), an
atypical HGPS strain (AG07493), and three normal cell strains (GM00969 and AG09602 dermal
fibroblasts and BJ foreskin fibroblasts). Rabbit anti-SIRT6 primary antibody was used at a
concentration of 1µg/ml in 5% blocking buffer and goat anti-rabbit IgG secondary antibody was
diluted in 5% blocking buffer for a final concentration of 0.25µg/ml.
2.4.2 To Confirm Expression of Ectopic SIRT6 Following SIRT6 Infection of HGPS and Normal
Fibroblasts. The samples tested included: AG01972 (PD20.5); AG01972+SIRT6 (PD20.5);
AG11513 (PD18); AG11513+SIRT6 (PD20.5); GM00969 (PD27.5); and, GM00969+SIRT6 (PD27.5).
2.4.3 To Confirm Successful Induction of Progerin in Normal Fibroblasts after Inducing with
Doxycycline. For this analysis, anti-progerin primary antibody (1µg/µl) diluted and goat antimouse IgG secondary antibody (0.25µg/ml) were used. Samples tested included: GM00969
PD19.5, HDF-progerin (no induction), HDF-progerin (1000ng/ml dox for 4 days), HDF-progerin

27

(750ng/ml dox for 8 days), HDF-progerin (750ng/ml dox for 14 days), AG11513 PD11.5, and
AG11513 SIRT6 PD20.5.
2.4.4 To Test Whether Ectopic Progerin Expression Alone Reduces SIRT6 Protein Levels in
Normal Fibroblasts. To determine whether the production of progerin affects the expression of
SIRT6 protein, the following lysates were resolved by SDS-PAGE and immunoblotted with
antibodies directed against SIRT6 as described above: GM00969 PD19.5, HDF-progerin (no
induction), HDF-progerin (1000ng/ml dox for 4 days), HDF-progerin (750ng/ml dox for 8 days),
HDF-progerin (750ng/ml dox for 14 days), AG11513 PD11.5, and AG11513 SIRT6 PD20.5.
2.4.5 To Test the Enzymatic Deacetylase Activity of SIRT6. Acetylated H3K9 levels were
examined in HGPS and normal fibroblasts before and after ectopic SIRT6 expression. Samples
tested included: GM00969 PD33, GM00969 SIRT6 PD28.5, AG11513 PD18, and AG11513 SIRT6
PD20.5. Mouse monoclonal anti-acetyl-Histone H3 (Ac-Lys9) primary antibody (2µg/ml) and
goat anti-mouse IgG secondary antibody (0.25µg/ml) were used.
β-actin, an abundantly expressed protein in all eukaryotic cells, was used as a loading control
(0.2µg/ml) for all Western blot analyses.
2.5 Immunofluorescence (IF) staining
All samples were seeded as triplicates on acid-treated and ethanol sterilized coverslips at a
density of 105 cells per 22x22mm coverslip (Fisher Scientific) in 6 well dishes. Cells were
cultured overnight and the culture medium was then removed followed by one washing step
with 2ml 1X Phosphate-Buffered Saline (PBS, Gibco). The cells were fixed by adding 2ml of fresh
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3.7% paraformaldehyde for 10 minutes at room temperature (RT). The cells were washed 3
times in PBS, 5 minutes each washing step, then permeabilized using PBS + 0.1% Triton X-100
and incubated for 15 minutes at RT. The cells were washed three times in PBS, 5 minutes each
and then blocked for 15 minutes using 2ml per well of blocking buffer, consisting of 1X PBS +
0.15% glycine + 1% BSA. Primary antibodies were diluted in blocking buffer to the appropriate
concentration (1-2µg/ml) as recommended by the manufacturer. 50µl of diluted primary
antibody was spotted onto parafilm and coverslips were added and placed in a humid container
overnight at 4°C. Coverslips were returned to 6 well dishes to be washed three times, 10
minutes each wash in 1X PBS. Secondary antibody was diluted to its appropriate concentration
and 50µl of diluted antibody was spotted on parafilm and coverslips placed on top. Coverslips
were incubated for 45 minutes – 1 hour in the dark at RT followed by 3 washing steps, 3ml/well
1X PBS, 10 minutes each wash. 10µl of Vectashield® mounting medium for fluorescence with
DAPI (1.5µg/ml DAPI) (Vector Laboratories, Inc.) was dropped onto each precleaned double
frosted microscope slide (Fisher Scientific) for each coverslip containing immunolabeled cells.
The blue-fluorescent DAPI allows for the visualization of nuclei as it specifically intercalates into
DNA. Clear nail polish was used to seal the edges of the coverslips to avoid drying out. Slides
were protected from the light at 4°C until images were captured at 40x and 100x objectives
using the Nikon Eclipse E8000M fluorescence microscope and SPOT™ software.
100 nuclei for each sample was scored using Image J, the image processing and analysis
application. The software scores the total number of foci in a given field and the average
number of 53BP1 positive foci per nucleus was quantified by dividing the total number of foci
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by the total number of nuclei. A uniform threshold value was set throughout all the samples to
ensure consistent detection of foci.
2.5.1a To Determine the Extent of DNA Damage in HGPS Fibroblasts Compared to Normal
Fibroblasts and as a Function of Replicative Age. The frequency of 53BP1-positive foci was
analyzed in the following samples: Normal fibroblasts (GM00969 PD29, GM00969 PD41, and
AG09602 PD17) and HGPS fibroblasts (AG11513 PD11.5 and AG11513 PD24). GM00969 PD29.5
+ 0.75µM Adriamycin was used as a positive control. Positive controls for the presence of DNA
double strand breaks (DSBs) were generated by acutely treating normal fibroblasts, GM00969,
in the dark with culture medium containing 0.75 µM adriamycin for 2 hours. Adriamycin is an
intercalative antitumor drug which when exposed to mammalian cells, induces DNA strand
breaks, increased activity of p53 and senescence.50,51 After 2 hours, culture media was replaced
with fresh media and cells were left to recover for 24 hours before fixing for
immunofluorescence. Mouse anti-53BP1 primary antibody was diluted in blocking buffer to a
concentration of 0.8µg/ml and Alexa Fluor 568 secondary antibody was used at a concentration
of 4µg/ml. Adriamycin emits a red fluorescence essentially in the same spectrum as Alexa 568,
therefore, Adriamycin treated controls were stained with Alexa Fluor 488 secondary antibody
to ensure any fluorescence emitted was solely due to the presence of 53BP1 foci. A negative
control (GM00969 PD26.5) was included to support the validity of staining and identify the
presence of any experimental artifacts. As a negative control, cells were incubated with the
antibody diluent (1% BSA) without the primary antibody followed by incubation with labeled
secondary antibodies.
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2.5.1b To Determine Whether Ectopic SIRT6 Expression Mitigates DNA Damage in HGPS Cells.
The frequency of 53BP1-positive foci was assessed in the following samples: AG11513 PD11.5
and AG11513 SIRT6 PD12using our standard protocol as described above.
2.5.2 SIRT6 Immunofluorescence
2.5.2a To Confirm the Initial Western Blotting Trend, Endogenous Levels of SIRT6 Protein in
HGPS Fibroblasts Compared to Normal Fibroblasts Were Analyzed via IF Assay. SIRT6 levels
were examined in AG11513 PD17 compared to GM00969 PD27 as well as a no primary antibody
(GM00969) control. Samples were stained using rabbit anti-human SIRT6 primary antibody
diluted in 1%BSA to a concentration of 10µg/ml and Alexa rabbit 488 secondary antibody
(4µg/ml). The immunofluorescence assay was carried out as previously described (see section
2.5).
The intensity of SIRT6 staining was compared qualitatively among samples.
2.5.2b To Confirm SIRT6 Overexpression Following Lentiviral Infection. Following SIRT6
infections, levels of SIRT6 overexpression were assessed in the following samples: GM00969
PD32, GM00969 SIRT6 PD32.5, AG11513 PD16, AG11513 SIRT6 PD 23.5, and a no primary
antibody control. Evidence of SIRT6 overexpression compared to uninfected samples was
concluded qualitatively.
2.6 Senescence-Associated β-Galactosidase Activity Assay
Histochemical staining for SA-β-gal was used to detect senescent cells in HGPS (AG11513
PD10.5 and PD20.5) and normal (GM00969 PD21.5 and PD43, and AG09602 PD19 and PD32.5)
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fibroblast cultures. Senescence was assessed in HGPS fibroblasts vs. normal fibroblasts as well
as as a function of replicative age.
Each sample was seeded at subconfluency (ie. 1x105 cells/6 well dish) in triplicate and the assay
was performed at pH6.0 using the Senescence β-Galactosidase Staining Kit (Cell Signaling
Technology, Inc.). As a positive control for senescence, GM00969 cells were exposed to
0.75µM Adriamycin for 2 hours and maintained in supplemented medium for 4 days prior to
fixing.51 The extent of senescence could was examined by comparing intensities of βgalactosidase histochemical staining and assessing cellular morphology to further support
existence of a senescent state. During cellular senescence, fibroblasts change their morphology
from a spindle shape to an enlarged, flattened, and irregular shape.

2.7 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
To detect levels of endogenous SIRT6 mRNA in HGPS fibroblasts relative to GM00969
fibroblasts, cells were collected at 70% confluency and RNA for each sample was isolated with
the SV Total RNA Isolation System (Promega) according to the manufacturer’s protocol. 1µg of
RNA was reverse transcribed using the High-Capacity cDNA Reverse Transcription kit (Applied
Biosystems). The thermal cycler (PTC-100 Programmable Thermal Controller, MJ Research,Inc.)
was programmed using the following conditions: 25°C for 10 minutes, 37°C for 120 minutes,
85°C for 5 minutes and then a 4°C ‘soak’ until the samples were retrieved. 20µl (1µg) of reverse
transcription reaction for each sample was used for qRT-PCR using primers for SIRT6 (forward,
5’-CCCACGGATCTGGACCA; reverse, 5’-CTCTGCCAGTTTGTCCCTG) and endogenous control,
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cyclophilin

A

(PPIA)

(forward,

5’-GCATGATCGGGAGGGTTTACT;

reverse,

5’-

TCCTTGCCACTCCTATTCCTT). PPIA is a cytosolic and moderately abundant protein that functions
in cellular protein folding and protein interactions. Its stable expression allows for the
quantification of the gene of interest by comparing the gene expression to this internal
standard.55 All reactions were carried out in triplicate on the ABI 7900HT Fast Real-Time PCR
System. SIRT6 expression levels were calculated by relating mean cycle threshold (C t) ± SD of
triplicates values to the mean values of the endogenous control, PPIA.55
2.8 Cell Proliferation
Proliferation rates of HGPS fibroblasts were compared to those of normal fibroblasts from
young and old donors. Proliferation rates were also assessed as a function of replicative age
(low vs. high population doublings). The parameter used to assess proliferation rates was the
population doubling time (PDT), which is the time taken for the culture to increase twofold in
the middle of the exponential phase of growth. The PDTs were assessed as follows: in a 12-well
plate, each sample was seeded in triplicates for each time point i.e. 24, 48 and 72 hours. After
24hrs, the first plate was trypsinized with 0.2ml trypsin, incubated for 5 minutes followed by
the addition of 0.2ml medium (total volume 0.4ml). The cells were then counted in each of the
three wells using a hemocytometer. Sampling was repeated at 48 and 72hrs. A fourth well for
each sample was seeded and stained with methylene blue (0.2% methylene blue + 50%
methanol/deionized H2O) at each time point to assess uniform distribution of cells in the wells
and qualitatively compare rates of cell growth with time.
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Number of cells/well = Average number of cells counted x volume of trypsin+media used (ml) x
104
The doubling time was then calculated using the software http://www.doubling-time.com. The
equation for calculating doubling time is:
Doubling time (hours) = t x log2 / logNt - logNo
Where t: time period; Nt: number of cells at time t; No: initial number of cells.
The average doubling times and standard error from each replicate were then calculated.
2.11 Statistical Analysis
Data was analyzed using 2-tailed Student’s t test and a P value less than 0.05 was considered
significant.
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3 RESULTS

3.1 HGPS fibroblasts express lower levels of SIRT6 protein than normal fibroblasts, which
positively correlates with DNA damage, β-galactosidase positivity and reduced proliferative
capacity.
3.11 HGPS Fibroblasts Express Lower Endogenous Levels of SIRT6 than Normal Fibroblasts.
In a previous study, the generation of Sirt6-/- mice resulted in mice with multiple shared
phenotypes of those with Hutchinson-Gilford Progeria Syndrome.42 The levels of SIRT6 protein
have not been examined in HGPS fibroblasts, therefore, I first hypothesized that HGPS
fibroblasts express lower levels of SIRT6 protein than normal fibroblasts. 3 different HGPS
strains (AG11513, AG01972 and AG03199), an atypical HGPS strain (AG07493), and three
normal cell strains (GM00969 and AG09602 dermal fibroblasts and BJ foreskin fibroblasts) were
assessed for progerin and SIRT6 expression. As expected, Western analysis revealed that only
typical HGPS cells (AG11513, AG01972 and AG03199) expressed progerin (Figure 5A). SIRT6
expression was noticeably reduced in the HGPS strains compared to normal fibroblasts (Figure
5B). It also worth noting that typical HGPS strains expressed lower SIRT6 levels than the atypical
HGPS strain.
To confirm these findings, typical HGPS (AG11513 PD17) and normal fibroblasts (GM00969
PD27) of young replicative ages were immunolabeled with anti-SIRT6 primary antibody
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followed by anti-rabbit Alexa 488 secondary antibody in an immunofluorescence assay.
AG11513 nuclei displayed much weaker signal intensity when compared to GM00969,
indicating reduced SIRT6 protein in the HGPS nuclei (Figure 5D).
To determine whether SIRT6 was also reduced at the transcriptional level in HGPS cells, RNA
was isolated from normal fibroblasts, an atypical HGPS strain, and a typical HGPS strain. qRTPCR was conducted using primers for SIRT6 and the endogenous control, PPIA. The reactions
were carried out in triplicate and mRNA levels were normalized to the endogenous control.
mRNA levels of SIRT6 in the atypical and typical HGPS strains mirrored the protein levels
observed in the Western blot. Although statistically insignificant, atypical, and to a greater
extent, typical HGPS strains expressed lower levels of SIRT6 mRNA when compared to a normal
fibroblast (GM00969) control (Figure 5C).
Collectively, these results indicate that typical HGPS fibroblasts express lower levels of SIRT6
than normal fibroblasts and that SIRT6 expression may be at least in part regulated at the
transcriptional level. Atypical HGPS fibroblasts exhibit higher levels of endogenous SIRT6 than
typical HGPS fibroblasts, which could be attributed to their lack of progerin production.
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Figure5. Assessment of endogenous SIRT6 levels in HGPS and normal fibroblasts. (A) Western
analysis to characterize typical HGPS strains by their expression of the mutant protein progerin,
the result of a single nucleotide mutation (G608G) in exon 11 of the LMNA gene. Unlike atypical
HGPS fibroblasts and normal fibroblasts, typical HGPS strains AG03199, AG11513 and AG01972
express progerin. (B) Typical HGPS strains express markedly lower levels of SIRT6 protein than
atypical HGPS and normal fibroblasts. Blots were probed first with progerin, and then
sequentially reprobed for SIRT6 and β-actin (loading control). (C) Quantitative RT-PCR was used
to detect mRNA levels of endogenous SIRT6 expression in AG07493 and AG01972 fibroblasts.
Relative quantities were normalized to PPIA. AG01972 fibroblasts expressed about 47% less
SIRT6 mRNA than normal fibroblasts while AG07493 fibroblasts only 15% less. Error bars
represent SD of replicates. (D) Representative immunofluorescence images of AG11513 and
GM00969 cells at a 40X magnification. SIRT6 is stained in green and nuclei, stained with DAPI, in
blue.
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Low levels of SIRT6 were observed specifically in progerin-expressing fibroblasts. So does the
expression of progerin alone have an effect on the levels of SIRT6 protein expressed, or are
other factors specific to HGPS cells responsible for the relatively lower SIRT6 levels? To answer
this question, human diploid fibroblasts (HDF) transfected with an EGFP-progerin construct
were treated with doxycycline to induce progerin production and the levels of SIRT6 protein
were analyzed (Figure 6). HDFs that were not induced by doxycycline to produce progerin did
not express detectable progerin protein when probed with anti-progerin antibody (Figure 6A).
Only after exposing the fibroblasts to 1000ng/ml doxycycline for 4 days, cells produced an
abundance of progerin indicating a tightly regulated inducible system (Figure 6B). An
exaggerated level of progerin protein in HDFs resulted in a down-regulation of SIRT6 protein.
However, when progerin was expressed at levels similar to HGPS fibroblasts, no effect was seen
on SIRT6 expression. There was also no effect on SIRT6 protein levels with increasing time of
progerin production in culture.
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Figure 6. Effect of Progerin Production on SIRT6 Protein Expression. (A) Western Blot showing
endogenous SIRT6 and progerin levels in HDF without doxycycline treatment and GM00969
normal fibroblasts. (B) Western Blot showing the effect of progerin production on SIRT6 levels.
Induced progerin is tagged to EGFP and has a higher molecular weight (~100 kDa) than
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endogenous progerin (70kDa) expressed by HGPS fibroblasts. An exaggerated level of progerin
protein in HDFs resulted in a downregulation of SIRT6 protein. However, when progerin was
expressed at levels similar to HGPS fibroblasts, no effect was seen on SIRT6 expression. There
was no effect on SIRT6 protein levels with increasing time of progerin production in culture.

3.12 HGPS Fibroblasts Exhibit a Higher Frequency of 53BP1 Foci than Normal Fibroblasts.
DNA damage in the form of DNA double-strand breaks (DSBs) can be assessed by the presence
of 53BP1 (p53-binding protein 1) foci. 53BP1 is one of the mediators of the DNA damage repair
pathway following the detection of DSBs and is required for the phosphorylation of p53, which
ultimately leads to cell cycle arrest.36 If the DNA damage is reversible, p53 activity decreases
after quick repair, however, when repair is slow or incomplete p53 activity is sustained. A
higher frequency of 53BP1 foci corresponds to a greater number of unrepaired DSBs. An
immunofluorescence assay was used to analyze the frequency of 53BP1 foci in HGPS fibroblasts
compared to normal fibroblasts (Figure 7D-G). The average frequency of 53BP1-positive foci per
nucleus was determined in AG11513 PD11.5 and PD24, GM00969 PD29 and PD41, AG09602
PD17, and GM00969 PD29.5 acutely treated with adriamycin for 2 hours (positive control). Cells
were seeded in triplicate and stained with mouse anti-53BP1 primary antibody followed by
Alexa Fluor 568 (red) secondary antibody. The nuclei of adriamycin-treated cells, without being
probed for Alexa Fluor 568 secondary antibody, emit red fluorescence due to the accumulation
of the chemotherapeutic drug and were therefore probed with Alexa Fluor 488 (green)
secondary antibody (Figure 7A,B).
100 nuclei from each replicate were scored for all of the samples using Image J. A uniform
threshold value was set across all samples where a focus was only scored if it was above the
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minimum threshold value. The average frequencies of 53BP1-positive foci ± SD of replicates
were then graphed for each sample (Figure 7H). Approximately 21 foci per nucleus were seen
for the positive control sample. AG11513 (PD11) fibroblasts showed 5.9 foci per nucleus, which
was not significantly higher than normal GM00969 (PD29) fibroblasts (5.2 foci per nucleus) (pvalue= 0.7). However, the 18 PD difference between samples should be taken into account.
AG09602 PD17 (92 year old donor) had a significantly higher frequency of 53BP1 foci compared
to GM00969 PD29 (2 year old donor) fibroblasts (p-value=0.00135). For both GM00969 and
AG11513 fibroblasts, there was no significant difference in the number of 53BP1 foci with
increasing replicative age (p-values= 0.87 and 0.18, respectively). Together, these results
indicate that HGPS fibroblasts at a relatively young replicative age (PD11) display a level of DNA
damage similar to normal fibroblasts at a much older population doubling (PD29). These results
along with findings in the literature56 suggest that with age, there is a decreasing efficiency in
DNA repair as indicated by the abundant presence of DNA damage-induced foci of 53BP1.
Additionally, no significant increase in the number of 53BP1 foci was observed in 2 year old
normal fibroblasts with increasing replicative age suggesting that the occurrence of DSBs may
not increase with increasing time in culture in young normal fibroblasts, or perhaps the cells
were not aged long enough. However, AG11513 fibroblasts showed a gradual increase in the
frequency of 53BP1 foci with increasing replicative age with approximately 6 foci per nucleus at
PD11.5 (p-value=0.7) and 8 foci per nucleus at PD24 (p-value=0.18). Continuing to age the HGPS
cells further may show a significant increase in the incidence of DSBs.
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Figure 7. Incidence of DSBs Represented By Frequency of 53BP1 Foci. (A) Representative
immunofluorescence images of no primary antibody negative controls. Adriamycin-treated cells
emit red fluorescence without Alexa 568 (red) secondary antibody. (B) No primary antibody
negative control for Adriamycin-treated cells with Alexa 488 (green) secondary antibody. (C) No
primary antibody negative control for GM00969 cells with Alexa 568 (red) secondary antibody.
Images were taken at a 40X magnification and nuclei were stained blue with DAPI.
Representative images displaying 53BP1 foci at 100X magnification of GM00969+0.75µM Adr
(D), GM00969 PD29 (E), AG11513 PD11.5 (F), and AG11513 PD 24 (G). (H) Bars represent the
frequency of 53BP1 foci per nucleus in each sample. Data were derived from three independent
experiments. Error bars represent standard error (SE) of replicates. For each sample the p value
was compared to GM00969 PD29. Statistically significant results have a p value less than 0.05
(*p<0.05).

3.13 HGPS Fibroblasts Senesce Prematurely Compared to Normal Fibroblasts.
Senescence-associated β-Galactosidase (SA β-gal) was used as a biomarker to qualitatively
assess the senescence in HGPS fibroblasts compared to normal fibroblasts from young
(GM00969) and old (AG09602) donors. We had hoped to determine the frequency of β-gal
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positivity but were unable due to limitations of using this assay (see discussion). A widespread
histochemical staining reaction together with the adoption of an enlarged and flattened cellular
morphology, were collectively highly consistent with a senescent state. Fibroblasts stained
using SA β-Gal included: GM00969 PD21.5 and PD43, AG09602 PD19 and PD32.5, and AG11513
PD10.5 and PD20.5. Using this assay allows us to qualitatively examine the premature
senescence seen in HGPS fibroblasts. GM00969 and AG09602 at young PDs exhibited slight
staining, (possibly background staining) however, they still displayed the typical fusiform-cell
morphology shared by low passage fibroblasts (Figure 8B-E). Conversely, AG11513 HGPS
fibroblasts at a young PD of 10.5 had a more flattened, irregular shaped morphology with
darker staining comparable to the positive control. The senescent phenotype of the AG11513
fibroblasts was more pronounced with older replicative age (PD20.5) (Figure 8F-G).

45

POSITIVE CONTROL
(GM00969 PD23.5 +0.75µM AdR)

GM00969 PD21.5

A

GM00969 PD43

C

B

AG09602 PD19

D

AG0962 PD32.5

E

AG11513 PD20.5

AG11513 PD10.5

F

G

Figure 8. Senescence-Associated β-gal Staining in Cultured Fibroblasts. Images were captured
at 20X magnification. (A) To induce senescence, GM00969 fibroblasts were acutely treated with
0.75µM Adriamycin for 2 hours. Fresh medium was then added and cells remained in culture
for 4 days before fixing and staining. B,D,F: early passage fibroblasts; C,E,G: late passage
fibroblasts. Late passage AG11513 fibroblasts displayed a flattened senescent morphology with
darker histochemical staining.
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3.14 HGPS Fibroblasts Have a Longer Doubling Time than Normal Fibroblasts and Doubling
Time Lengthens with Increasing Replicative Age.
The proliferation rates of HGPS fibroblasts and normal fibroblasts were assessed via doubling
times (Figure 9). Young AG11513 fibroblasts (PD12.5) had a slightly higher doubling time (49.7±
4.5 hours) than GM00969 fibroblasts (38.7 ± 2.97 hours), however this was not statistically
significant (p-value=0.11). Both HGPS strains, AG11513 and AG01972, had significantly higher
doubling times than normal fibroblasts of similar PD (p-value= 0.03 and 0.04, respectively) and
doubling time increased with increasing replicative age (AG11513 PD12.5 to PD20 (pvalue=0.07). Additionally, there was a significant increase in the doubling times of normal
fibroblasts as replicative age increased from PD23.5 to PD40.5 (p-value=0.04).
.
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Figure 9. Proliferation Rates of HGPS and Normal Fibroblasts as a Function of Replicative Age.
Bars represent the doubling time (hours) of each cell strain. For each sample, the replicate
values for doubling time were compared to GM00969 PD23.5 (dark blue bar). At comparable
population doublings, AG11513 fibroblasts (PD20) had a significantly higher doubling time
(137.8%) than GM00969 fibroblasts (PD23.5) (p-value=0.03). Another HGPS strain (AG01972
PD26) had almost triple the doubling time of normal fibroblasts albeit being 14.5 PDs younger.
With increasing replicative age, population doubling times of normal and HGPS fibroblasts
approximately doubled.
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Results from Aim 1 of this study uncovered a novel finding that typical (progerin-expressing)
HGPS fibroblasts express lower levels of SIRT6 protein and mRNA than normal fibroblasts and
even atypical HGPS fibroblasts. The expression of progerin alone did not seem to have a direct
effect on the protein levels of SIRT6. Via the evaluation of 3 markers of cellular senescence,
HGPS fibroblasts were found to exhibit more DNA damage than normal fibroblasts, display a
pronounced senescent cellular morphology at young PDs, and have a longer population
doubling time than normal fibroblasts at an equal or higher PD. On these grounds, it would be
of great interest to examine whether SIRT6 overexpression in HGPS fibroblasts will prevent the
premature senescence, a major contributing factor to this accelerated aging phenotype. The
second half of this study aims to answer this question
3.2 Overexpressing SIRT6 Protects HGPS fibroblasts From DNA Damage, Premature
Senescence and Slow Proliferation Rates.
SIRT6 has been found to be crucial in maintaining a normal replicative lifespan and preventing
premature senescence in human fibroblasts.44 SIRT6-/- in cells results in a shortened replicative
lifespan and increased levels of SA-β-gal staining. Furthermore, SIRT6 has also been implicated
in DNA repair since SIRT6 depletion has been linked to an increased frequency of
phosphorylated γH2AX DNA damage foci.44 Comparable cellular defects exist between SIRT6-/and HGPS fibroblasts. Additionally, the aforementioned study demonstrating the abnormalities
of SIRT6-deficient mice which overlap with progeroid pathologies42, along with the study
showing that male mice overexpressing SIRT6 have a significantly longer lifespan than wild-type
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mice42, have collectively led to the proposal that overexpressing SIRT6 in HGPS fibroblasts may
prevent the senescence-associated phenotypes in HGPS fibroblasts.
The first objective of Aim 2 was to stably overexpress SIRT6 in HGPS and normal fibroblasts
using a lentiviral vector. The lentiviral vector (pCDH-CMV-MCS-EF1-Puro) was chosen as it offers
stable, efficient and long-term expression of the target gene in almost any mammalian cell
including those that are post-mitotic. Owing to the poor proliferation capacity of HGPS cells,
this lentivector construct was the delivery vehicle of choice. An empty vector control was used
to develop a controlled system to exclusively examine the effects of SIRT6 overexpression in
HGPS and normal fibroblasts. After 5 days of puromycin treatment, to select for cells
successfully expressing the lentiviral vector, cells carrying the empty vector grew poorly
compared to their SIRT6-overexpressing and uninfected parental counterparts (Figure 10 A-C).
Unfortunately, we were unable to expand sufficiently for subsequent comparable analyses with
SIRT6 overexpressing cells. As a result, uninfected cells were used as controls. SIRT6 was
overexpressed in 2 different HGPS strains (AG01972 PD10 and AG11513 PD11) and one normal
strain (GM00969 PD25) as indicated by Western blotting analysis (Figure 10D) and confirmatory
immunofluorescence assay verifies that SIRT6 overexpression was nuclear in cellular
localization (Figure 10E-H).
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Figure 10. SIRT6 Overexpression in HGPS and Normal Fibroblasts. Representative bright-field
images of (A) Uninfected parental AG01972 PD17, (B) AG09172+SIRT6 PD20.5, (C)
AG01972+empty vector PD18.5. The same outcome was seen with AG11513+empty vector
(Images not shown). Image (C) showing cellular debris and unhealthy, dying fibroblasts
compared to (A) and (B). Images captured at 20x magnification under a phase-contrast
microscope. (D) Western blot analysis of SIRT6 overexpression in AG11513, AG01972 and
GM00969 fibroblasts. E-H: Representative immunofluorescence images showing nuclear
specific SIRT6 overexpression. Fibroblasts overexpressing SIRT6 show a visibly more intense
signal than their uninfected counterparts. Cells were immunostained with antibodies against
SIRT6 and Alexa 488 and counterstained with DAPI. Images were captured at 100x
magnification. (I) No primary antibody (SIRT6) negative control at 40x magnification.

3.21 SIRT6 Overexpression Reduces the Occurrence of DNA-Damage Induced DSBs.
As shown in Figure 11, overexpressing SIRT6 in AG11513 HGPS fibroblasts resulted in a
significant and dramatic reduction in the frequency of 53BP1 foci (p-value= 0.01). AG11513
HGPS fibroblasts displayed 5.87 53BP1-positive foci per nucleus while AG11513 fibroblasts
overexpressing SIRT6 reduced this frequency to about 2.5.
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Figure 11. Incidence of DSBs represented by frequency of 53BP1 foci ± SIRT6. Bars represent
the frequency of 53BP1 foci per nucleus in AG11513 fibroblasts ± SIRT6. Data were derived
from three independent experiments. Error bars represent standard error (SE) of replicates. The
p value was of AG11513 SIRT6 was compared to the uninfected AG11513 control. Statistically
significant results have a p value less than 0.05 (*p<0.05).

3.22 SIRT6 Overexpression Delays Replicative Senescence in HGPS Fibroblasts.
SA β-gal activity was used in order to determine whether SIRT6 overexpression prevents the
premature senescent phenotype of HGPS fibroblasts (Figure 12). AG11513 PD20.5 fibroblasts
have a more flattened, irregular, senescent morphology compared to the same strain at
PD10.5. However, AG11513 SIRT6 fibroblasts still showed a healthy, spindle-like morphology at
PD20.5. Consistent results were seen when this assay was repeated in an independent
experiment (images not shown).
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Figure 12. Senescence-Associated β-gal Staining in Cultured Fibroblasts. 1.5x104 cells were
seeded in triplicates in a 48-well dish and stained with β-gal staining solution 24 hours after
plating. (A,B) Representative images of AG11513 PD10.5 and PD20.5 and (C,D) AG11513 SIRT6
PD11 and PD20.5 were captured at 20X magnification.

3.23 SIRT6 Overexpression Improves the Proliferative Capacity of HGPS Fibroblasts.
Since HGPS fibroblasts have significantly longer doubling times than normal fibroblasts, the
proliferative capacity of HGPS fibroblasts overexpressing SIRT6 was examined. The PD times of
AG11513 (PD12.5), AG11513 SIRT6 (PD12), AG11513 (PD20) and AG11513 SIRT6 (PD18.5) were
assessed. Results showed that ectopic expression of SIRT6 significantly reduced doubling times
compared to uninfected controls (AG11513 PD12.5 vs. AG11513 SIRT6 PD12 (p-value=0.04) and
AG11513 PD20 vs. AG11513 SIRT6 PD18.5 (p-value=0.04)). Furthermore, as HGPS fibroblasts
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aged in culture their doubling time dramatically increased (p-value=0.06), however, the
increase in doubling time was much less pronounced in HGPS fibroblasts overexpressing SIRT6
(p-vaule=0.33).

120

Doubling time (hrs)

100

80

*
60

40

20

0
AG11513 PD12.5

AG11513 SIRT6 PD12

AG11513 PD 20

AG11513 SIRT6 PD18.5

Cell strain

Figure 13. Proliferation Rates of AG11513 Fibroblasts ± SIRT6 Overexpression and as a
Function of Replicative Age. Bars represent the doubling time (hours) of each sample. The
doubling times of AG11513 SIRT6 were compared to parental AG11513 strains at comparable
PDs. At early and late PDs, SIRT6 overexpression led to a significant reduction in the doubling
times of HGPS fibroblasts (p-value=0.04). Statistically significant results have a p value less than
0.05 (*p<0.05).

55

3.3 The Beneficial Effects of SIRT6 Overexpression on Cellular Senescence May Be Specific to
HGPS Fibroblasts.
To determine whether the effects of SIRT6 overexpression on the biological endpoints
examined is specific to HGPS fibroblasts or has the same effect on normal fibroblasts, DNA
damage, β-gal positivity, and proliferative capacity were assessed in GM00969 normal
fibroblasts overexpressing SIRT6.
Preliminary results indicated that there was no significant difference in the average number of
53BP1 foci per nucleus (p-value=0.58) (Figure 14A). Results from the SA-β-gal assay also showed
no noticeable difference in staining intensities or the cellular morphology (Figure 14B). Finally,
although slightly shorter, the population doubling time of GM00969 SIRT6 fibroblasts was not
significantly reduced when compared to the uninfected parental control (GM00969 PD 23.5)
(Figure 14C).
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Figure 14. The Effects of SIRT6 Overexpression on GM00969 Normal Fibroblasts. (A) Average
number of 53BP1-positive foci per nucleus. Data were derived from scoring 100 nuclei per
sample. Error bars represent standard error (SE) (p-value=0.58). (B) Senescence-associated β57

gal staining in GM00969 fibroblasts ±SIRT6 overexpression. 1.5x104 cells were seeded in
triplicates in a 48-well dish and stained with β-gal staining solution 24 hours after plating.
Images were captured at 20X magnification. (C) Proliferation rates of GM00969 fibroblasts ±
SIRT6 overexpression. Bars represent the doubling time (hours) of each cell strain. Replicate
values for doubling time were compared to GM00969 PD29. (p-value=0.16). Statistically
significant results have a p value less than 0.05 (*p<0.05).

3.4 The Enzymatic Activity of SIRT6 as a Histone 3 Lysine 9 Deacetylase.
In order to determine the mechanism of action by which SIRT6 is exerting its biological function,
the levels of acetylated H3K9 were examined in normal GM00969 fibroblasts and AG11513
fibroblasts ± SIRT6 overexpression via western blot (Figure 15). There seems to be a slight
reduction in the levels of acetylated H3K9 in AG11513+SIRT6 fibroblasts, however there was no
marked difference in the levels of acetylated H3K9 before and after ectopic SIRT6 expression.
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Figure 15. Western Blot to Assess Levels of Acetylated H3K9. HGPS (AG11513 PD18 and
AG11513 SIRT6 PD20.5) and normal (GM00969 PD33 and GM00969 SIRT6 PD28.5) fibroblasts
were assessed for the levels of acetylated H3K9 they expressed ± SIRT6 overexpression. There
was no obvious reduction in the levels of acetylated H2K9.
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To summarize findings from aim 2 of this study, SIRT6 was successfully and stably
overexpressed in HGPS and normal fibroblasts. Immunofluorescence analysis confirmed that
the overexpression was nuclear in cellular localization. In HGPS fibroblasts, SIRT6
overexpression resulted in a significant reduction (p-value= 0.01) in the frequency of 53BP1 foci
per nucleus indicating a marked reduction in DNA damage in these cells. Also, the flattened
senescent morphology previously seen in young PD HGPS fibroblasts was not observed in HGPS
fibroblasts overexpressing SIRT6. Rather, these fibroblasts exhibited a spindle-like cellular
morphology typical of healthy-looking fibroblasts derived from young donors. The proliferative
capacity of HGPS fibroblasts overexpressing SIRT6 was also remarkably improved, with
significantly shortened population doubling times when compared to parental uninfected HGPS
fibroblasts (p-value=0.04). The same biological end-points were examined in normal fibroblasts
± SIRT6, showing slightly reduced β-gal positive staining and a shorter doubling time in normal
fibroblasts overexpressing SIRT6 (not statistically significant).
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4. DISCUSSION

HGPS is a childhood accelerated aging disease caused by a spontaneous point mutation in the
LMNA gene. Progerin accumulates on the inner nuclear membrane, causing abnormalities in
nuclear structure and function such as transcription, DNA replication, DNA repair, and the
regulation of euchromatin-heterochromatin transitions. The nuclear architecture dysfunction
not only leads to an accumulation of DNA damage in HGPS cells, but has also been proposed to
be a contributing factor to telomere structure and function impairment. As a result of an
impairment in DNA repair, DNA damage, namely in the form of DSBs, activates the DNA
Damage Response pathway, which ultimately leads to cell cycle arrest and senescence. Cellular
senescence has been reported as one of the major hallmarks of the aging process. As previously
described, there are a number of cellular defects which lead to senescence such as telomere
dysfunction and perturbations in chromatin organization. Changes in DNA methylation
patterns, histone modifications and chromatin remodeling all constitute epigenetic
modifications that also play a role in the pathological aspects of aging. Specific examples of
alterations in heterochromatin factors in HGPS include decreased levels of heterochromatin
protein (HP1), H3K9me3, and H3K27me3 and increased levels of H4K20me3. A recent study by
Shah et al.67 reported that lamin B1 levels decline during senescence and a forced lamin B1
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reduction leads to premature senescence, concomitantly resulting in altered chromatin
structure and reorganization in the human epigenome such as H3K4me3-enriched domains,
which have also been detected in prematurely senescent HGPS cells. The results from this study
indicated an indirect link between the formation of H3K4me3-enriched domains and
accelerated tissue and organismal aging, possibly due to premature senescence chromatin
changes.
SIRT6, a NAD+-dependent protein deacetylase and ADP ribosyltransferase, has been studied
extensively as a potential anti-aging factor. SIRT6 represents an epigenetically significant
enzyme whose loss of function results in a progeroid phenotype in mice and whose gain of
function extends longevity in mice, linking premature aging to altered chromatin at telomeres.

Despite the common degenerative phenotypes seen in SIRT6-deficient mice and HGPS, neither
SIRT6 expression levels nor the manipulation of SIRT6 have been studied in HGPS fibroblasts.
Thus, the first goal of this study was to determine whether HGPS fibroblasts express lower
levels of SIRT6 than normal fibroblasts. Moreover, cellular features such as persistent DNA
damage, β-galactosidase positivity and reduced proliferative capacity, which collectively
suggest cellular senescence, were assessed in HGPS fibroblasts relative to normal fibroblasts
of young and old donor age in order to generate baseline data for the overexpression studies
in Aim 2.
Here we show that SIRT6 protein levels were markedly reduced in all 3 typical HGPS strains
compared to normal fibroblasts. Unlike typical HGPS strains, atypical HGPS cells do not express
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progerin and were found to express higher SIRT6 levels than typical HGPS cells. The fact that
only progerin expressing cells expressed low endogenous levels of SIRT6 raised a question,
whether a relationship exists between progerin production and SIRT6 expression. The level of
SIRT6 protein expression was also assessed in 3 independent immunofluorescence (IF) assays
showing a consistent reduction in signal intensity in typical HGPS fibroblasts compared to
normal fibroblast controls. qRT-PCR was conducted to explore whether SIRT6 was reduced at
the transcriptional level. Preliminary results showed a significant reduction in the mRNA levels
of SIRT6 in typical HGPS cells relative to normal fibroblasts, which suggests that SIRT6
expression may be at least in part regulated at the transcriptional level. However, mRNA
assessment must be repeated in order to ensure validity of results and reproducibility.
Nonetheless, the consistency of protein results with typical HGPS cell strains derived from 3
different donors obtained from western analysis coupled with the IF assays allows for a
confident conclusion that typical HGPS fibroblasts express lower levels of SIRT6 than normal
fibroblasts.
Three different markers of cellular senescence were examined in typical HGPS fibroblasts and
compared to normal fibroblasts of comparable population doublings. The first endpoint
examined was DNA damage in the form of DNA double-strand breaks. The frequency of 53BP1
foci in typical HGPS fibroblasts (AG11513, 8 year old donor) was examined by IF and compared
to normal strains from 2 year old (GM00969) and 92 year old (AG09602) donors. Results
revealed that AG11513 cells at PD11.5 had an average frequency of 5.9 foci per nucleus while
GM00969 PD29 had 5.2 foci per nucleus. These PDs were considered relatively young for both
samples. In similar culture conditions, HGPS fibroblasts were seen to have a maximum
63

replicative capacity at PD30-35, while GM00969 fibroblasts grew exponentially until PD40-50.
Although there was no statistical significance (p-value= 0.7 ) between the average number of
53BP1 DNA damage foci in HGPS vs. normal fibroblasts, the closeness in the frequency of foci
considering the 18 population doubling gap is consistent with early onset of DNA damage in the
HGPS fibroblasts. Furthermore, although not significant, a trend towards an increase in foci
frequency with increasing replicative age was observed in AG11513 PD11.5 versus PD24, but
not in GM00969 PD29 versus PD41. This is suggestive that in culture, an accumulation of DNA
damage can be seen in HGPS fibroblasts with time, while the number of 53BP1 foci in normal
fibroblasts remains seemingly constant. It is necessary, however, to observe the frequency of
53BP1-positive foci in AG11513 fibroblasts at a closer PD to the normal fibroblasts to which we
are comparing. We predict a significantly higher frequency of 53BP1 DNA-damage foci in HGPS
fibroblasts than in normal fibroblasts of the same PD. Finally, AG09602 normal fibroblasts at
PD17 showed a significantly high frequency of 53BP1 foci (15 foci per nucleus) which is
consistent with reports that DNA damage accumulates with older physiological age.62
The second biological end point examined as a biomarker for cellular senescence was SA β-gal
activity. This assay was used to determine the frequency of senescence in HGPS fibroblasts
compared to normal fibroblasts from young (GM00969) and old (AG09602) donors. The
frequency of β-gal positive cells could not be quantitatively determined due to a non-specific
blue hue that renders it difficult to differentiate a β-gal positive cell from a non-specifically
stained cell. As a result, classifying cells as being positively or negatively stained would be a
subjective matter and irreproducible. Also, in cells that are in fact positively stained, it is
difficult to quantify the intensity of blue staining and cells with strong, moderate or weak blue
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staining would all be considered equally positive. An additional limitation of using this assay is
that under the microscope, different fields of the same sample may have different staining
intensities depending on the confluency of cells. SA β-gal staining has been found to be more
intense in areas where cells are more confluent. Therefore, it is important to ensure that the
distribution of cells in replicate wells is uniform and multiple fields are scored. Despite these
limitations, the SA β-gal assay was chosen to assess cellular senescence due to its simplicity and
robust detection of β-gal activity in cells exhibiting an enlarged and flattened senescent
morphology. By means of visual inspection, young AG11513 fibroblasts (PD20.5) exhibited
staining intensities comparable to GM00969 fibroblasts almost 23 PDs higher. Also, while low
passage GM00969 and AG09602 fibroblasts displayed the typical fusiform morphology of
healthy fibroblasts, AG11513 fibroblasts as early as PD10.5 displayed an enlarged, flattened
cellular morphology consistent with a senescent state. Findings from the SA β-gal studies
showed that normal and HGPS fibroblasts displayed more intense staining with increasing time
with culture and HGPS fibroblasts exhibited senescent cellular phenotypes at remarkably low
passage numbers suggestive of premature replicative senescence. Here, we used SA β-gal as a
qualitative assessment of cellular senescence; however, alternative methods can be employed
in order to generate future quantitative data. An assay developed by Shiush et al.58 employs the
SA β-gal staining technique followed by the capture and digital analysis of the stained cells.
They have reported that this method of quantifying SA β-gal activity is accurate and
reproducible in detecting cellular senescence. Markers of cellular senescence such as the cellcycle inhibitors p16 and p21 may also be looked at as an alternative method of identifying
senescent cells.
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There is persistent activation of the ATM/ATR pathway in HGPS cells due in part, to the
accumulation of DNA damage. As a result, there is a reduction in cell cycle progression and
replicative capacity which contribute to pathological aging.29,33 The doubling times of HGPS and
normal fibroblasts was the third biological end point assessed in order to investigate their
replicative state. As anticipated, fibroblasts from 2 different HGPS donors had significantly
longer doubling times than normal fibroblasts of comparable population doublings. Also in
normal and HGPS fibroblasts, a trend towards longer doubling times with increasing replicative
age was observed. The interpretation of this data suggests that HGPS fibroblasts have a lower
proliferation capacity than normal fibroblasts, which progressively lessens with replicative age.
Data generated from the first part of this study revealed for the first time that HGPS fibroblasts
express lower levels of SIRT6 protein and mRNA than normal fibroblasts. This comparative
analysis also demonstrated that HGPS fibroblasts exhibit more DNA damage, more pronounced
β-gal staining coupled with a senescent cellular morphology, and a longer population doubling
time than normal fibroblasts at an equal or higher PD, as previously reported.63 This begs the
question: Will SIRT6 overexpression in HGPS fibroblasts prevent (or possibly reverse) this
accelerated aging phenotype? The second part of this study encompassed a series of in vitro
experiments to begin to answer this question.
We first stably overexpressed SIRT6 in HGPS and normal fibroblasts using a lentiviral vector. In
order to ensure the biological end points assessed were solely due to the effects of the SIRT6
gene, an empty lentivector control was included. However, contrary to the SIRT6 infected cells,
after a couple of population doublings, the empty vector control cells were no longer viable,
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providing an initial indication that SIRT6 was exerting a growth advantage to the HGPS
fibroblasts. Then, paralleling the senescence characterization in Aim 1, we assessed the
frequency of 53 BP1 DNA damage foci, β-gal histochemical staining and proliferative capacity in
SIRT6-infected HGPS fibroblasts compared to parental controls. We conjectured that sustained
SIRT6 expression may prevent or at least minimize the DNA damage and the development of
senescence-like features in HGPS cells.
Here we indeed demonstrate that overexpression of SIRT6 in HGPS fibroblasts resulted in a
marked reduction in the frequency of 53BP1 foci when compared to uninfected HGPS control
fibroblasts. This significant reduction in the average number 53BP1 positive foci per nucleus
correlates with a fewer incidence of DSBs and ultimately a reduction in DNA damage.
Moreover, SA β-gal staining was examined ± SIRT6 infection in HGPS fibroblasts. As earlier
mentioned, low passage HGPS cells exhibited extensive staining as well as an irregular,
senescent cellular morphology. Visibly, there was no reduction in intensity of β-gal staining
after SIRT6 overexpression, which may be attributable to possible nonspecific staining (i.e. all
cells were stained blue to some degree). However, the classic senescent morphology previously
seen in the HGPS fibroblasts as early as PD10.5 was not observed in the SIRT6 infected HGPS
fibroblasts even at PD20.5. It seems that ectopically expressing SIRT6 is either delaying the
onset of senescence to some extent or possibly mitigating the senescent cellular morphology.
Again, more quantitative approaches need to be employed before making a compelling
conclusion.
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Finally, the effect of SIRT6 overexpression on the proliferative capacity of HGPS fibroblasts was
examined. A significant reduction in the doubling times of SIRT6 infected HGPS fibroblasts was
observed compared to parental uninfected controls at both young and older population
doublings. Although statistically insignificant, the doubling time of uninfected HGPS fibroblasts
doubled as they aged in culture from PD12.5 to PD20. Whereas, there was almost no change in
the doubling time of SIRT6 infected HGPS fibroblasts from PD12 to PD18.5. It can be concluded
from these findings that SIRT6 overexpression led to an improvement in proliferative capacity in
HGPS fibroblasts.
To further examine whether SIRT6 overexpression offers a growth advantage to normal
fibroblasts as well as HGPS fibroblasts, the effects of SIRT6 overexpression were assessed in
normal GM00969 fibroblasts. There was no significant difference in the frequency of 53BP1
DNA damage foci in normal fibroblasts overexpressing SIRT6 compared to uninfected normal
fibroblasts. Additionally, although slightly less intense in GM00969+SIRT6, β-galactosidase
staining was equally minimal in GM00969 with (PD29.5) or without (PD23.5) ectopic SIRT6
expression. We observed shorter population doubling times in GM00969 SIRT6 PD28.5
fibroblasts when compared to GM00969 PD23.5; however, these results were also statistically
insignificant. Overall, preliminary results indicated that SIRT6 overexpression did not have
pronounced beneficial effects on normal fibroblasts as it did on HGPS fibroblasts. However, we
have established that normal fibroblasts express substantial SIRT6 protein levels, the
overexpression of which seems to offer no additional benefit in terms of the reduction of DNA
damage and prevention of senescence. Assessing these end points after aging the normal
fibroblasts longer in culture to when they typically present a more pronounced senescent
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phenotype could provide more insight into effect of SIRT6 on preventing the onset of
senescence. Also, using siRNA to silence SIRT6 expression in normal fibroblasts and evaluating
the effects of minimal/no SIRT6 protein in normal fibroblasts could be a plausible experiment to
conduct. It would be of great interest to examine whether re-introducing SIRT6 in the SIRT6
knock down normal fibroblasts results in a rescue of the senescent phenotype.
In summary, the goal of this study was to determine whether HGPS fibroblasts exhibited lower
levels of SIRT6 than normal fibroblasts and whether reduced SIRT6 expression contributes to
the premature senescence phenotype of HGPS fibroblasts. Cellular senescence is one of the
major hallmarks of aging, and this study aimed to delve into several of the cellular defects
leading to cellular senescence and how they may be prevented. Epigenetic changes such as
altering histone methylation have been found to induce lifespan extension in nematodes and
flies.58,59 For this reason, along with previous studies assessing the role of SIRT6 on genomic
stability and longevity,41,45 it is reasonable to examine the effects of manipulating a histonemodifying enzyme such as SIRT6 on the various aspects of aging in HGPS. This study revealed
that typical HGPS fibroblasts express lower levels of SIRT6 protein and mRNA than atypical
HGPS fibroblasts and normal fibroblasts derived from young and old donors. The expression of
progerin protein is what sets apart typical HGPS fibroblasts from atypical HGPS and normal
fibroblasts. For this reason, it can be proposed that there may be a link between progerin
expression and SIRT6 expression levels. However, when progerin expression was induced in
normal HDFs to levels similar to those of HGPS fibroblasts, no effect on the expression of SIRT6
protein was observed. Thus, it is possible that progerin is not directly interfering with SIRT6
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expression in HGPS cells and there may be other mechanisms unique to HGPS, by which these
cells express relatively lower levels of SIRT6.
The presence of DNA damage, β-galactosidase positivity, and low proliferative capacity were
anticipated in HGPS fibroblasts and all agreed with previous reports.14,29 However, do these
cellular defects correlate with the low levels of SIRT6 expressed in HGPS fibroblasts? The results
of the experiments conducted following SIRT6 overexpression showed a significant reduction in
DNA damage and improvement in proliferative capacity. β-gal activity did not appear to be
affected by SIRT6 overexpression and remains to be quantitatively measured; however, the
SIRT6 infected HGPS fibroblasts exhibited a healthier cellular phenotype, which could be
indicative of a mild improvement of the pronounced senescent phenotype of HGPS fibroblasts.
Taken together, these findings indicate that low SIRT6 expression levels in HGPS fibroblasts
positively correlates with premature senescence, which can be prevented by overexpressing
SIRT6. This is further indication that epigenetic changes may be a contributing factor to the
aging process and manipulation of the histone deacetylase SIRT6 may improve several aspects
of aging. It is necessary, however, to identify the mechanism by which SIRT6 is modulating
senescence. To begin to elucidate mechanism, we attempted to demonstrate that SIRT6
overexpressing fibroblasts exhibit an overall reduction in the level of acetylated H3K9, as would
be expected for cells ectopically expressing functional SIRT6. However, western blot analysis
revealed no reduction in acetylated H3K9 levels in HGPS and normal fibroblasts overexpressing
SIRT6 compared to uninfected parental controls. A possible reason for this could be that SIRT6
has poor H3K9 deacetylase activity in vitro. Gil et al.60 revealed that SIRT6 showed significant
deacetylase activity when histones were packaged as nucleosomes, as opposed to using
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unpackaged histones. Therefore, determining SIRT6 functionality is a critical limitation of the
data set and must be further explored before conclusions can be made on the mechanism of
action of the SIRT6 enzyme.
Assuming the characterized H3K9 deacetylase activity of SIRT649, hyperacetylation due to SIRT6
deficiency is thought to interfere with the association of DNA repair proteins at the telomeres
suggesting that an altered chromatin state may be required for the recruitment of telomere
binding proteins.62 It would be helpful to assess the recruitment of DNA repair proteins such as
DNA-PKs to DSBs following SIRT6 overexpression to further elucidate mechanistic details
concerning the functional role of SIRT6 in the context of DNA repair and genomic stability.
Furthermore, a hyperacetylated chromatin state, particularly at the telomeres, is associated
with an opened chromatin structure which leads to the replication and metabolism of
telomeres. Ectopically expressing SIRT6 may lead to a reduction in acetylated H3K9 levels and
consequently a condensed chromatin structure and transcriptional silencing. This may prove
very beneficial in HGPS since they originally have short telomeres and silencing their
transcription may prevent the progressive telomere shortening which occurs during replication.
In this regard, SIRT6 expression in HGPS fibroblasts may play a role in preventing DNA damageinduced and telomere-induced senescence (Figure 16).
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Figure 16. A proposed schematic summarizing the effects of SIRT6 on HGPS cells.
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This study has shown important implications of manipulating SIRT6 to counteract the
premature cellular senescence in HGPS and ultimately prevent the accelerated aging
phenotype. Studies have shown that SIRT6 deficiency produces premature aging phenotypes
coinciding with those observed in HGPS, while overexpressing SIRT6 promotes longevity in male
mice.39,41-45 In this context, our findings that HGPS fibroblasts express low levels of SIRT6 and
that overexpressing SIRT6 positively correlates with an attenuation of the cellular defects
contributing to premature senescence suggest that increasing the levels of this protein may be
a viable approach to delay aging in HGPS. It is necessary however, to assess the end points
examined over a longer duration to determine whether SIRT6 overexpression helps to elongate
the lifespan of HGPS cells. Due to the common involvement of progerin in both HGPS and
normal aging, it will be of great interest to see if the mechanism of action of SIRT6 is also true in
normal aging.30
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